Fertility Clinical Trial
— WOWOfficial title:
Multicentric Clinical Trial to Improve Blastocyst Utilisation Rate (in Relation to 2 PN Embryos) by Group Culture of Human Embryos in WOW Dishes.
NCT number | NCT02010424 |
Other study ID # | 2013/819 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 2014 |
Est. completion date | December 2015 |
Verified date | November 2022 |
Source | University Hospital, Ghent |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In cattle less than 10% of the embryos develop to the blastocyst stage when embryos are cultured individually, however when bovine embryos are cultured in groups a typical 25-35% of blastocysts can be observed. This tendency, i.e. improved embryo development in group culture, has also been demonstrated in other mammalian species, such as mouse, cat and human. The main reason for this beneficial outcome of group culture has been ascribed to the presence of autocrine factors, which are factors secreted by preimplantation embryos that act upon the embryo itself or the neighboring embryos . Although group culture systems are common in in vitro production systems for animal embryos, it is rarely done in human settings, where individual follow-up of the embryo during the whole culture period is of utmost importance. Recently a CE-labelled culture device has been designed for human embryos, that allow to combine the benefits of both group culture approaches and individual culture. The WOW dish is commercially available by Primo Vision and consists of 9 small microwells on the bottom of the plate, so that the embryos can be cultivated individually in a microwell, but covered by the same drop of culture medium. In this clinical randomized trial, 158 patients will be included of which half of the fertilized oocytes will be cultured individually (standard culture system) and half of the fertilized oocytes will be cultured in group in a WOW dish, both during five days of culture. The aim of this study is to increase the number of blastocysts suitable for transfer or cryopreservation by culturing the embryos in WOW dishes.
Status | Completed |
Enrollment | 158 |
Est. completion date | December 2015 |
Est. primary completion date | December 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 40 Years |
Eligibility | Inclusion Criteria: - Sperm obtained by ejaculation - Conventional IVF/ICSI - At least 10 fertilized oocytes (2 PN) Exclusion Criteria: - |
Country | Name | City | State |
---|---|---|---|
Belgium | Antwerp University Hospital, Centre for Reproductive Medicine | Edegem | |
Belgium | Ghent University Hospital | Ghent |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Ghent |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Blastocyst utilisation rate | number of blastocysts out of fertilized oocytes observed 5 days after fertilization that can be used for the patient (fresh transfer or cryopreservation) | 5 days after fertilization | |
Secondary | Morphologic evaluation | Morphologic evaluation according to the Gardner score (Gardner and Schoolcraft, 1999) | 5 days after fertilization | |
Secondary | change in embryo development | morphologic evaluation at day 2, 3 and 4 after fertilization | at day 2, 3 and 4 after fertilization | |
Secondary | pregnancy rate | endocrine pregnancy by measuring hCG in blood sample on day 15 after embryo transfer and clinical pregnancy confirmed by ultrasound, 5 weeks after embryo transfer. | day 15 and week 5 after embryo transfer | |
Secondary | life birth rate | birth of a baby nine months after embryo transfer | 9 months after embryo transfer | |
Secondary | change in secretome | embryo conditioned medium will we collected at day 3 and day 5 after fertilization in eppendorf tubes and kept in -80°C until all samples are collected and they will be analyzed with mass spectrometry to compare the secretome (secreted proteins by the preimplantation embryo). | day 3 and day 5 after fertilization |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02759705 -
Bladder Exstrophy (FIVES FertIlity Vesical Exstrophy Sexuality)
|
||
Not yet recruiting |
NCT02534857 -
A Study Comparing a Shorter Exposure of Oocyte to Spermatozoa Versus a Standard Incubation on the Live Birth Rate of In-vitro Fertilization Treatment
|
N/A | |
Enrolling by invitation |
NCT01803893 -
Prognostic Value of PIF Detection in Embryo Culture Media Correlation With Pregnancy Outcome
|
N/A | |
Completed |
NCT01888744 -
Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist
|
Phase 4 | |
Terminated |
NCT01173276 -
Intrauterine Insemination In HIV-Discordant Couples
|
N/A | |
Not yet recruiting |
NCT03680937 -
Methods for Fertility Preservation: Impact of Vitrification on in Vitro Matured Oocytes
|
||
Completed |
NCT03455062 -
Fertility Study of Women Who Received Organ Transplantation
|
N/A | |
Completed |
NCT02736214 -
Reproductive Life Plan-based Counseling With Men
|
N/A | |
Completed |
NCT01895192 -
Sperm Morphology by High Magnification in Fertility Men
|
N/A | |
Terminated |
NCT01614704 -
Impact of Sequential Chemotherapy on Young Patients Breast Cancer Treated Fertility
|
||
Terminated |
NCT01232972 -
Oocyte Cryopreservation
|
N/A | |
Terminated |
NCT01268592 -
Fertility Preservation in Female Cancer Patients
|
N/A | |
Completed |
NCT01012596 -
Creighton Model Effectiveness, Intentions and Behaviors Assessment (CEIBA)
|
||
Completed |
NCT00390754 -
Usefulness of Home Pregnancy Testing
|
N/A | |
Completed |
NCT00231504 -
Study of Follicle Stimulating Hormone (FSH) Receptor in Women With Low Antral Follicle Count
|
Phase 1 | |
Completed |
NCT03345264 -
The Find Your PATHS (Pragmatic Assessment of a Tool to Help Survivors) to Sexual Health and Parenthood Study
|
N/A | |
Recruiting |
NCT05414812 -
Intervening on Women's Health for Rural Young Breast Cancer Survivors
|
N/A | |
Active, not recruiting |
NCT02661932 -
Fertility Preservation in Breast Cancer Patients
|
Phase 4 | |
Recruiting |
NCT06172504 -
Ejaculation Frequency and Semen Parameters
|
||
Recruiting |
NCT02878434 -
Fertility Preservation in Young Women With Cancer
|